Neoenergia (NEOE3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Injected energy increased 8.2% year-over-year in 2Q24, driven by higher temperatures and customer growth.
Net income reached R$815 million in 2Q24, up 12% year-over-year.
Cash EBITDA rose 3% to R$2.4 billion in 2Q24, with cumulative growth of 92% since IPO.
Transmission projects advanced, with R$0.2 billion of RAP released in 1H24 and further releases expected.
CapEx for 2Q24 was R$2.3 billion, with R$4.2 billion invested in 1H24, mainly in networks and transmission.
Financial highlights
Revenue and gross margin grew 3-5% year-over-year in 2Q24, with net operating revenue at R$10.98 billion.
EBITDA increased 12% to R$2.97 billion in 2Q24; cash EBITDA up 3% to R$2.4 billion.
Net income for 2Q24 was R$815 million (+12% year-over-year); 1H24 net income was R$1.94 billion (flat year-over-year).
CapEx totaled R$2.3 billion in 2Q24 and R$4.2 billion in 1H24, focused on network expansion and transmission.
Provisions for delinquency (PECLD) and loan loss provisions improved across most distributors.
Outlook and guidance
Transmission investment cycle expected to conclude in 2025, with annualized RAP projected to reach R$1.2 billion by year-end 2024.
Focus remains on recurring CapEx in distribution, operational efficiency, and expanding the renewable portfolio.
Regulatory changes allow for 30-year renewal of distribution concessions, impacting 4 of 5 distributors.
No participation planned in the September 2024 transmission auction due to lack of competitiveness and land issues.
Progress in defining conditions for early renewal of distribution concessions.
Latest events from Neoenergia
- Record net income, strong asset rotation, and 75% share price surge defined 2025.NEOE3
Q4 202512 Feb 2026 - Cash EBITDA up 4% and network growth offset lower net income; CapEx and quality on track.NEOE3
Q3 202419 Jan 2026 - EBITDA and revenue rose in 2024, but net income was pressured by higher financial costs.NEOE3
Q4 202421 Dec 2025 - EBITDA up 6%, net income down 11%, with asset rotation and deleveraging focus.NEOE3
Q1 202521 Dec 2025 - EBITDA up 13%, net income up 10%, and shares rose 55.5% YTD amid strong operational results.NEOE3
Q3 202510 Dec 2025 - Net income doubled in 2Q25 on tax credits, with strong EBITDA and asset rotation.NEOE3
Q2 202523 Jul 2025